SiRNA-mediated lncRNA ANRIL knockdown enhances the sensitivity of gastric cancer cells to doxorubicin
Open Access
- 11 October 2020
- journal article
- research article
- Published by DoNotEdit in Iranian Red Crescent Medical Journal
- Vol. 22 (10)
- https://doi.org/10.32592/ircmj.2020.22.10.120
Abstract
Background: Long non-coding RNAs (lncRNAs) play pivotal roles in carcinogenesis and the development of drug resistance in various malignancies. Objectives: The current study aimed to explore the impact of antisense non-coding RNA in the INK4 locus (ANRIL) silencing on proliferation and the sensitivity of KATO III gastric cells to the doxorubicin as a common chemotherapeutic agent. Methods: The KATO III cells were transfected with ANRIL siRNA (si-ANRIL) using Lipofectamine™2000 reagent. Following that, the relative ANRIL levels were determined by quantitative Real-Time PCR. Trypan blue assay was conducted to observe the tumor cell proliferation following the transfection. Moreover, the MTT assay was performed to identify the cytotoxic effects of doxorubicin and si-ANRIL alone or in combination on KATO III cells. The effects of si-ANRIL/doxorubicin on KATO III cells migration and apoptosis were assessed by wound healing assay and ELISA cell death method, respectively. Results: The results showed that the si-ANRIL significantly diminished ANRIL expression level in a time-dependent manner contributing to the distinct repression of cell growth and enhanced apoptosis. Furthermore, the si-ANRIL synergistically elevated the cytotoxic impacts of doxorubicin. Additionally, the ANRIL down-regulation dramatically promoted its induction of apoptosis. Moreover, KATO III cells transfected with si-ANRIL and exposed with doxorubicin revealed significantly reduced invasion capability and enhanced apoptosis rate. Conclusion: These results demonstrated that the knock-down of lncRNA ANRIL could be a potential therapeutic strategy to trigger apoptosis and circumvent doxorubicin-resistance.Keywords
This publication has 27 references indexed in Scilit:
- Emerging Role of miRNAs in the Drug Resistance of Gastric CancerInternational Journal of Molecular Sciences, 2016
- Long noncoding RNAs in gastric cancer: functions and clinical applicationsOncoTargets and Therapy, 2016
- lncRNAs and microRNAs with a role in cancer developmentBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2016
- LncRNAs: emerging biomarkers in gastric cancerFuture Oncology, 2015
- Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistanceBiochemical and Biophysical Research Communications, 2015
- The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung AdenocarcinomaPLOS ONE, 2015
- Long noncoding RNAs: Novel insights into gastric cancerCancer Letters, 2015
- Long Noncoding RNA MRUL Promotes ABCB1 Expression in Multidrug-Resistant Gastric Cancer Cell SublinesMolecular and Cellular Biology, 2014
- A novel long non-coding RNA-ARA: Adriamycin Resistance AssociatedBiochemical Pharmacology, 2014
- ANRIL: Molecular Mechanisms and Implications in Human HealthInternational Journal of Molecular Sciences, 2013